TF and sarcoma: Indeed, TFs can be targeted by inhibiting their interactions with DNA or protein co-factors or by decreasing their protein stability through targeting the proteasome.219,220 Aberrant TF activity plays a critical role in simple and complex karyotype sarcomas, and recently there have been advances to target oncogenic fusion TFs in sarcomas.